News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021
News Conference News AHA 2021 An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops Shelley Wood November 15, 2021
News Daily News Cardiologist Robert Califf Nominated to Head FDA—Again Shelley Wood November 12, 2021
News Conference News TCT 2021 DCBs in Coronaries? Some Good News, but More Work Needed L.A. McKeown November 06, 2021
Presentation TCT 2021 Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective Presenter: George Van Hare November 05, 2021
Presentation TCT 2021 Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective Presenter: Mintu Turakhia November 05, 2021
Presentation TCT 2021 Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective Presenter: Kan Fang November 05, 2021
Presentation TCT 2021 Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective Presenter: Meir Shinnar November 05, 2021
Presentation TCT 2021 Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective Presenter: William Abraham November 05, 2021
Presentation TCT 2021 Tricuspid Valve Interventions - Adding Quality of Life to Years, from Industry Perspective Presenter: Suzanne Arnold November 05, 2021
Presentation TCT 2021 Pragmatic Clinical Trials: The Future is Now? Presenter: Sreekanth Vemulapalli November 04, 2021
Presentation TCT 2021 Adapting Clinical Trials to a Black Swan Event, from Industry Perspective Presenter: Sandeep Brar November 04, 2021
Presentation TCT 2021 Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective Presenter: Andrew Farb November 04, 2021
Presentation TCT 2021 Impact of the COVID-19 Pandemic on FDA: Review of Changes and Looking Ahead Presenter: William Maisel November 04, 2021